BRAF (V600E) mutation in isthmic malignant thyroid nodules

被引:3
|
作者
Campenni, A. [1 ]
Giovanella, L. [2 ,3 ]
Alibrandi, A. [4 ]
Siracusa, M. [1 ]
Ruggeri, R. M. [5 ]
Baldari, S. [1 ]
机构
[1] Univ Messina, Nucl Med Unit, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy
[2] Oncol Inst So Switzerland, Nucl Med, Bellinzona, Switzerland
[3] Oncol Inst So Switzerland, PET CT Ctr, Bellinzona, Switzerland
[4] Univ Messina, Dept Econ Business & Environm Sci & Quantitat Met, Messina, Italy
[5] Univ Messina, Dept Clin & Expt Med & Pharmacol, Endocrinol Sect, Messina, Italy
关键词
RISK; ABLATION; CANCER;
D O I
10.1111/cen.12858
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:152 / 153
页数:3
相关论文
共 50 条
  • [31] The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma
    Pelizzo, M. R.
    Dobrinja, C.
    Ide, E. Casal
    Zane, M.
    Lora, O.
    Toniato, A.
    Mian, C.
    Barollo, S.
    Izuzquiza, M.
    Guerrini, J.
    De Manzini, N.
    Boschin, I. Merante
    Rubello, D.
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (04) : 413 - 417
  • [32] A high-sensitivity cfDNA capture enables to detect the BRAF V600E mutation in papillary thyroid carcinoma
    Lee, Tae Hee
    Jeon, Hong Jae
    Choi, Jung Hyun
    Kim, Young Jun
    Hwangbo, Pil-Neo
    Park, Hyun Sung
    Son, Chae Yeon
    Choi, Hei-Gwon
    Kim, Ha Neul
    Chang, Jae Won
    Bu, Jiyoon
    Eun, Hyuk Soo
    KOREAN JOURNAL OF CHEMICAL ENGINEERING, 2023, 40 (02) : 429 - 435
  • [33] An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates
    Agrawal, Tanupriya
    Xi, Liqiang
    Navarro, Winnifred
    Raffeld, Mark
    Patel, Snehal B.
    Roth, Mark J.
    Klubo-Gwiezdzinska, Joanna
    Filie, Armando C.
    CYTOPATHOLOGY, 2022, 33 (03) : 344 - 349
  • [34] Investigation of BRAF V600E detection approaches in papillary thyroid carcinoma
    Chen, Dan
    Qi, Wenjing
    Zhang, Pengxin
    Zhang, Yunkun
    Liu, Ye
    Guan, Hongwei
    Wang, Lifen
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (02) : 303 - 307
  • [35] BRAF V600E mutation in papillary thyroid carcinoma: Prevalence and detection in fine needle aspiration specimens
    Dujardin, Fanny
    Pages, Jean-Christophe
    Collin, Christine
    de Calan, Loic
    Lecomte, Pierre
    Guyetant, Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (04) : 252 - 262
  • [36] Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma
    Curry, Jonathan L.
    Torres-Cabala, Carlos A.
    Tetzlaff, Michael T.
    Bowman, Christopher
    Prieto, Victor G.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2012, 31 (04) : 267 - 273
  • [37] Poorer Prognosis and Higher Prevalence of BRAF V600E Mutation in Synchronous Bilateral Papillary Thyroid Carcinoma
    Wang, Weibin
    Zhao, Wenhe
    Wang, Haiyong
    Teng, Xiaodong
    Wang, Haohao
    Chen, Xiangheng
    Li, Zhongqi
    Yu, Xiongfei
    Fahey, Thomas J.
    Teng, Lisong
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) : 31 - 36
  • [38] Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma
    Lu, Junliang
    Gao, Jie
    Zhang, Jing
    Sun, Jian
    Wu, Huanwen
    Shi, Xiaohua
    Teng, Lianghong
    Liang, Zhiyong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (01): : 793 - 799
  • [39] Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma
    Kim, Seo Ki
    Woo, Jung-Woo
    Lee, Jun Ho
    Park, Inhye
    Choe, Jun-Ho
    Kim, Jung-Han
    Kim, Jee Soo
    ENDOCRINE-RELATED CANCER, 2016, 23 (01) : 27 - 34
  • [40] The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation
    Rossi, Esther Diana
    Bizzarro, Tommaso
    Granja, Sara
    Martini, Maurizio
    Capodimonti, Sara
    Luca, Emilia
    Fadda, Guido
    Lombardi, Celestino Pio
    Pontecorvi, Alfredo
    Larocca, Luigi Maria
    Baltazar, Fatima
    Schmitt, Fernando
    ENDOCRINE, 2017, 56 (02) : 379 - 387